Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.85
Delayed Data
As of Oct 20
 -0.04 / -2.12%
Today’s Change
1.27
Today|||52-Week Range
7.10
+30.37%
Year-to-Date

Today’s Trading

Previous close1.89
Today’s open1.89
Day’s range1.80 - 1.90
Volume447,015
Average volume (3 months)301,171
Market cap$58.7M
Dividend yield--
Data as of 7:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-222.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.09+4.02%
EIGREiger BioPharmaceuti...+0.55+4.49%
NOVNNovan Inc+0.09+1.69%
NBYNovaBay Pharmaceutic...-0.15-3.37%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts